Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Open Label Clinical Trial to Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment

NCT05308836 is registered in ClinicalTrials.gov with Vinmec Research Institute of Stem Cell and Gene Technology as lead sponsor.

NCT NCT05308836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05308836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Open Label Clinical Trial to Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment
Lead sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Phase
Phase 1
Overall status
Completed
Start date
May 4, 2021
Completion date
December 30, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes